SNCA and synucleinopathy: The rationale for this strategy is based on the emerging central role of prion-like amplification and cell-to-cell propagation pathological α-synuclein aggregates as well as aggregate-mediated toxicity of α-synuclein in the pathogenesis of synucleinopathies.5